Figure 2.

Mutation status of TP53, PPM1D, H3F3A, IDH1 in the extended series. Mutational status as determined by Sanger sequencing is shown for BSGs (n=33) and thalamic gliomas (n=17).

Mutation status of TP53, PPM1D, H3F3A, IDH1 in the extended series. Mutational status as determined by Sanger sequencing is shown for BSGs (n=33) and thalamic gliomas (n=17).